-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Sertraline is a selective serotonin reuptake inhibitor (SSRI) drug that is widely used to treat depression, anxiety disorders, and other related conditions.
The chemical structure of sertraline is complex, and it is difficult to synthesize it through natural routes.
Therefore, various synthetic routes have been developed in the chemical industry to synthesize sertraline.
In this article, we will discuss some of the commonly used synthetic routes for the synthesis of sertraline.
- Rutchauw and Serpellini Method
One of the earliest methods for the synthesis of sertraline was developed by Rutchauw and Serpellini in 1972.
This method involved the reaction of safrole with methyl iodide in the presence of quinoline to form N-methyl-N-phenyl-1,2,3,4-tetrahydroisoquinoline-1-amine.
This intermediate was then subjected to a series of chemical reactions to form sertraline.
- Hilfe and Roux Method
The Hilfe and Roux method is another commonly used synthesis route for sertraline.
In this method, safrole is reacted with dimethyl sulfate in the presence of a Lewis acid catalyst to form a di-dimethylsulfonium salt.
This intermediate is then treated with sodium hydroxide and trimethylorthoformate to form N-methyl-N-phenyl-1,2,3,4-tetrahydroisoquinoline-1-amine.
The final product is then synthesized through a series of chemical reactions.
- Birch Reduction
The Birch reduction method is a widely used synthesis route for the synthesis of sertraline.
In this method, chlorpheniramine is reduced using sodium in ethanol to form N-methyl-N-phenyl-1,2,3,4-tetrahydroisoquinoline-1-amine.
This intermediate is then treated with various chemicals to form sertraline.
- Burroughs Wellcome Patent
The Burroughs Wellcome patent involves the synthesis of sertraline through a series of chemical reactions.
The process involves the reaction of a phenylhydrazine derivative with an ethyl acetate-chloride mixture, followed by treatment with dimedone and sodium hydroxide.
The final product is then synthesized through a series of chemical reactions.
- Merck Patent
The Merck patent involves the synthesis of sertraline through a series of chemical reactions.
In this process, phenylamine is reacted with ethyl iodide in the presence of a solvent to form N-(1-ethylpropyl)-phenylamine.
This intermediate is then treated with various chemicals to form sertraline.
In conclusion, there are several synthetic routes for the synthesis of sertraline in the chemical industry.
These methods involve a series of chemical reactions that transform the starting materials into the final product.
The choice of a specific synthetic route depends on various factors, including cost, availability of raw materials, and the desired yield.
It is important to note that the synthesis of sertraline requires careful handling of hazardous chemicals and should be carried out in a well-equipped laboratory by trained professionals.